Ernest Tong, MD
Urology · Davenport, FLNPI 1770015422
Payments from drug & device makers
Across 76 payments — averaging $446.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$31K
- Procept Biorobotics Corporation$568
- Teleflex LLC$454
- Medtronic$435
- Astellas Pharma US Inc$432
- Calyxo, Inc.$286
- plus $1K from 18 others
What the payments were for
- Grants$30,00088%
- Food & beverage$3,43610%
- Education$5172%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $30,509 |
| Procept Biorobotics Corporation | 5 | $568 |
| Teleflex LLC | 6 | $454 |
| Medtronic | 5 | $435 |
| Astellas Pharma US Inc | 5 | $432 |
| Calyxo, Inc. | 4 | $286 |
| Myriad Genetic Laboratories, Inc. | 9 | $217 |
| AbbVie | 4 | $180 |
| Urogen Pharma, Inc. | 2 | $167 |
| Pfizer | 6 | $156 |
| Cook Medical LLC | 1 | $93 |
| Axonics, Inc. | 4 | $90 |
| Seagen Inc. | 1 | $85 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Endo Pharmaceuticals Inc. | 2 | $35 |
| Verity Pharmaceuticals Inc. | 2 | $33 |
| Dentsply IH AB | 1 | $29 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $20 |
| BD | 1 | $18 |
| Photocure Inc | 1 | $17 |
| Laborie Medical Technologies Corp. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Davol Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL KIDNEY STONE DISEASE$30,000
- AquaBeam Robotic System$335
- CVAC Aspiration System$254
- INTERSTIM$225
- UroLift$172
- Barrigel$168
- AQUABEAM SYSTEM$161
- JELMYTO$150
- Lupron Depot$115
- LithoVue$103
- AMS$101
How this compares
$33,953 in reported general payments places this provider in the 85th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 156 | $1,726 |
| Estradiol | 21 | $1,371 |
| Methenamine Hippurate | 13 | $1,101 |
| Cefdinir | 80 | $802 |
| Finasteride | 61 | $741 |
| Solifenacin Succinate | 26 | $531 |
| Ketorolac Tromethamine | 34 | $496 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $417 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 33 | $394 |
| Betamethasone Valerate | 15 | $334 |
| Ondansetron Hcl | 50 | $128 |
| Cephalexin | 29 | $98 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $68 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $62 |
| Sildenafil Citrate | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other urology in Davenport
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
- Fernando BiancoHialeah$2.2M
- Osvaldo PadronTampa$1.3M
- Mark Anthony GonzalgoMiami$1.1M
- Paul CrispenGainesville$1.1M
- Craig HermanPompano Beach$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.